Catalyst Wire Dossier Catalyst Wire Dossier

NovoMix 70

insulin aspart 70/30 · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NovoMix 70, covering 2014-06-24 to 2017-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects [Phase 1]

See pricing